ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
0.2029
-0.0026 (-1.27%)
At close: Sep 12, 2025, 4:00 PM EDT
0.2037
+0.0008 (0.39%)
After-hours: Sep 12, 2025, 7:51 PM EDT
ESSA Pharma Employees
ESSA Pharma had 35 employees as of September 30, 2024. The number of employees decreased by 15 or -30.00% compared to the previous year.
Employees
35
Change (1Y)
-15
Growth (1Y)
-30.00%
Revenue / Employee
n/a
Profits / Employee
-$721,863
Market Cap
9.60M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 35 | -15 | -30.00% |
| Sep 30, 2023 | 50 | 0 | - |
| Sep 30, 2022 | 50 | 25 | 100.00% |
| Sep 30, 2020 | 25 | 10 | 66.67% |
| Sep 30, 2018 | 15 | -10 | -40.00% |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EPIX News
- 4 days ago - Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025 - PRNewsWire
- 20 days ago - Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution - PRNewsWire
- 4 weeks ago - Essa Pharma Inc. Announces Ex-Dividend Date and Nasdaq Due Bill Trading for Previously Announced Cash Distribution - PRNewsWire
- 5 weeks ago - Essa Pharma Inc. Announces US$80 Million Cash Distribution to Shareholders - PRNewsWire
- 7 weeks ago - ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders - PRNewsWire
- 2 months ago - ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction - PRNewsWire
- 4 months ago - ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 - PRNewsWire
- 6 months ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX - PRNewsWire